| To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer Condition: Head and Neck Neoplasms Intervention: Drug: SCB01A Sponsor: SynCore Biotechnology Co., Ltd. Terminated |
| Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer Condition: Head and Neck Cancer Intervention: Drug: Panitumumab + paclitaxel Sponsors: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello; Amgen; Trial Form Support S.L. Completed |
| The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD) Conditions: Head and Neck Neoplasms; Hearing Loss Intervention: Sponsor: University of Manchester Not yet recruiting |
| A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients Condition: Head and Neck Cancer Intervention: Biological: PepCan Sponsor: University of Arkansas Not yet recruiting |
| NUTRI-HAB - Posttreatment Rehabilitation of Nutrition Impact Symptoms in Head and Neck Cancer Survivors Condition: Head and Neck Cancer Intervention: Other: NUTRI-HAB Sponsors: Odense University Hospital; REHPA The Danish Knowledge Centre for rehabilitation and Palliative Care; University of Southern Denmark; University College Copenhagen; Odense Patient Data Explorative Network; Rigshospitalet, Denmark Enrolling by invitation |
| Comparison of Endoscopic Visualization and CT Imaging of Head and Neck Cancers With Pathological Validation Study Condition: Head and Neck Cancer Intervention: Sponsor: University Health Network, Toronto Recruiting |
| A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer Condition: Head and Neck Cancer Interventions: Drug: BMX-001; Radiation: Radiation Therapy; Drug: Cisplatin Sponsors: BioMimetix JV, LLC; Duke University Recruiting |
| Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer Condition: Head and Neck Cancer Intervention: Drug: 99mTc-EC-DG Sponsor: University of Chicago Completed |
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients Condition: Head and Neck Cancer Interventions: Behavioral: Quality of Life Survey; Behavioral: Health Management Surveys; Other: Monitoring Devices; Behavioral: Symptoms Surveys; Behavioral: Device Usability Survey Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Active, not recruiting |
| Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema Conditions: Head and Neck Neoplasms; Head and Neck Lymphedema; Head and Neck Cancer Interventions: Device: Head and neck garments for pneumatic compression device; Drug: NIRFLI with ICG Sponsor: Tactile Medical Completed |
Ιατρική : Τα αισθητικά συστήματα της όρασης,ακοής,αφής,γεύσης και όσφρησης.
Δευτέρα 22 Απριλίου 2019
ClinicalTrials : Head and Neck Neoplasms
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: May 2017 Source: Molecular Immunology, Volume 85 Author(s): Yusui Sato, Satomi Inaba, Harumi Fukada, Takachika Azuma, M...
-
Related Articles [Olfactory receptors expressed in various non-olfactory tissues.] Clin Calcium. 2018;28(8):1124-1129 Authors: Ihara...
-
Olfactory and trigeminal systems interact in the periphery. Chem Senses. 2018 Jul 25;: Authors: Tremblay C, Frasnelli J Abstract Th...
-
Related Articles Different olfactory percepts evoked by orthonasal and retronasal odorant delivery. Chem Senses. 2018 Jul 02;: Autho...
-
On the meaning(s) of perceived complexity in the chemical senses. Chem Senses. 2018 Jul 16;: Authors: Spence C, Wang QJ Abstract Co...
-
Publication date: 15 April 2017 Source: NeuroImage, Volume 150 Author(s): Javier O. Garcia, Justin Brooks, Scott Kerick, Tony Johnson, Tim...
-
Related Articles Total Synthesis of (-)-Nodulisporic Acids D, C, and B: Evolution of a Unified Synthetic Strategy. J Am Chem Soc. 201...
-
Abstract l -Ornithine l -aspartate (LOLA), a stable salt of l -ornithine and l -aspartate, readily dissociates into its constituent amino ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου